Aleva is an emerging leader in the field of deep brain stimulation, having developed a game changing platform that is clinically proven in Parkinson’s treatment and providing strong differentiation, clearly supported by breakthrough publications in leading scientific journals. Aleva closed an $18M Series C investment round in May 2016.
Aleva
7MedTech